PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer

NCT01000025 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

720

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: PF-00299804
DRUG: Placebo

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]